---
layout: post
title: "Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h)"
date: 2026-02-04 21:49:22 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-18110
original_published: 2025-09-19 00:00:00 +0000
significance: 8.00
---

# Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h)

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** September 19, 2025 00:00 UTC
**Document Number:** 2025-18110

## Summary

The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b) in accordance with 21 U.S.C. 826(a) and is expediting publication of this determination to comply with the timeframes specified in 21 U.S.C. 826(h)(1).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/09/19/2025-18110/adjustment-to-the-aggregate-production-quota-for-lisdexamfetamine-and-d-amphetamine-for-conversion)
- API: https://www.federalregister.gov/api/v1/documents/2025-18110

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
